Literature DB >> 6757413

Biochemical requirements for intracellular invasion by Trypanosoma cruzi: protein synthesis.

M F Lima, F Kierszenbaum.   

Abstract

The effects of irreversible inhibition of protein synthesis by pactamycin in either infective forms of Trypanosoma cruzi or mammalian host cells on cellular invasion by this human pathogen were investigated. Treatment of bloodstream forms of T. cruzi with pactamycin markedly reduced their ability to bind either fibroblast-like cells of monkey origin or myoblasts of rat origin. The number of amastigote forms that could be established intracellularly was also significantly decreased with respect to control values obtained when mock-treated (medium alone) trypomastigotes were incubated with the cells. Pactamycin treatment also reduced the infectivity of T. cruzi trypomastigotes for mice as evidenced by both significantly reduced parasitemia levels and mortality rates when compared with those of control mice infected with mock-treated parasites. Inhibition of protein synthesis in the host cells neither prevented cell infection by untreated trypomastigotes nor altered the percentages of infected cells or the magnitude of the infection in vitro. These results indicate that protein synthesis is a requirement for cell invasion by T. cruzi and that the parasite can establish itself and replicate within cells relying on its own protein synthesis ability.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757413     DOI: 10.1111/j.1550-7408.1982.tb01337.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  6 in total

1.  Immunohistochemical detection of deposits of eosinophil-derived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas' disease.

Authors:  H A Molina; F Kierszenbaum
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

2.  Suppression of human lymphocyte responses by Trypanosoma cruzi.

Authors:  L A Beltz; F Kierszenbaum
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

3.  Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.

Authors:  F Kierszenbaum; H M Lopez; M B Sztein
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

4.  Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line.

Authors:  B Vray; P De Baetselier; A Ouaissi; Y Carlier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage.

Authors:  H A Molina; F Kierszenbaum
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.